Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine-like factor 1 (CKLF1) is a secreted cytokine belonging to the chemokine family, encoded by the CKLF gene on chromosome 16q22.1. Four isoforms exist (CKLF1-4) due to alternative splicing, with CKLF1 being the most studied. CKLF1 is a potent chemoattractant for neutrophils, lymphocytes, and monocytes, promoting cell migration, proliferation, and differentiation. It acts mainly through the CCR4 receptor, a G protein-coupled receptor on immune cells. CKLF1 is implicated in diverse physiological and pathological processes including immune regulation, inflammation, tissue regeneration, cardiovascular disease, cancer, and reproductive function. Though no marketed drugs directly target CKLF1, experimental antibodies and antagonists are being explored, with CKLF1 considered a promising therapeutic target especially for inflammatory diseases and cancer.
Antagonism of chemotactic signaling via CCR4; Inhibition of CKLF1-CCR4 interaction; Modulation of pathways (NF-κB, PI3K/Akt, JAK/STAT) involved in inflammation and tumorigenesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine-like factor 1 (CKLF1).